Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLP-1”

1,370 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,370 results

Not applicableStudy completedNCT00923962
What this trial is testing

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 35
Early research (Phase 1)Study completedNCT01272973
What this trial is testing

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 96
Post-approval studies (Phase 4)Study completedNCT03341429
What this trial is testing

Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response

Who this might be right for
Obesity
University College, London 70
Post-approval studies (Phase 4)UnknownNCT05870462
What this trial is testing

Semaglutide and Vascular Regeneration

Who this might be right for
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 100
Testing effectiveness (Phase 2)Study completedNCT06500429
What this trial is testing

Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist

Who this might be right for
Overweight and ObesityHealthy
Neurogastrx, Inc. 120
Large-scale testing (Phase 3)Study completedNCT03667053
What this trial is testing

Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children

Who this might be right for
Hypoglycemia
Zealand Pharma 42
Testing effectiveness (Phase 2)Study completedNCT01754337
What this trial is testing

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 30
Early research (Phase 1)Active Not RecruitingNCT03139305
What this trial is testing

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects

Who this might be right for
Obesity
AdventHealth Translational Research Institute 30
Post-approval studies (Phase 4)UnknownNCT00145353
What this trial is testing

Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

Who this might be right for
Type 1 Diabetes Mellitus
Odense University Hospital 16
Not applicableLooking for participantsNCT07495904
What this trial is testing

Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance

Who this might be right for
Obesity
Hellenic Mediterranean University 130
Not applicableStudy completedNCT02895672
What this trial is testing

GLP-1/Basal Insulin Combination Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Albany College of Pharmacy and Health Sciences 150
Not applicableStudy completedNCT01901861
What this trial is testing

Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Lund University 12
Post-approval studies (Phase 4)Ended earlyNCT02844907
What this trial is testing

Regulation of Insulin Secretion by the GLP-1 Receptor

Who this might be right for
Insulin Secretion
VA Office of Research and Development 6
Post-approval studies (Phase 4)Looking for participantsNCT07558863
What this trial is testing

Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613437
What this trial is testing

GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial

Who this might be right for
Intracerebral Hemorrhage
Chinese University of Hong Kong 200
Testing effectiveness (Phase 2)Study completedNCT02953665
What this trial is testing

Safety and Efficacy of Liraglutide in Parkinson's Disease

Who this might be right for
Parkinson Disease
Cedars-Sinai Medical Center 63
Post-approval studies (Phase 4)Study completedNCT02537834
What this trial is testing

Tofogliflozin GLP-1 Analogue Combination Trial

Who this might be right for
Type 2 Diabetes Mellitus
Kowa Company, Ltd. 65
Large-scale testing (Phase 3)Study completedNCT02735031
What this trial is testing

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Hypoglycemia
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00423501
What this trial is testing

A GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 306
Early research (Phase 1)Ended earlyNCT02550145
What this trial is testing

Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery

Who this might be right for
Hypoglycemia
Tracey McLaughlin 10
Next Page